Ionis Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Ionis Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Ionis Pharmaceuticals Inc
Rating: 1.269958375
Author: Trendlyne DVM scores

Momentum Trap

about

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, a...

75.68 -1.92 (-2.47%)

136.50% Gain from 52W Low

1.8M

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Ionis Pharma Inc is on 19 May 2026 for the purpose of 2026 RBC Capital Markets Global Healthcare Conference See details

Low Financial Strength

16.7 / 100

Expensive Valuation

7.3 / 100

Technically Moderately Bullish

60.9 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM

101

1Yr Price target upside is 33%

23 analysts

Ionis Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Ionis Pharma Inc Live Stock Price Today, Share Analysis and Chart

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, a...

136.50% Gain from 52W Low

SWOT Analysis

Ionis Pharma Inc Live Price Chart